The Pathogenesis of Sepsis and Potential Therapeutic Targets

被引:561
|
作者
Huang, Min [1 ,2 ]
Cai, Shaoli [1 ,2 ]
Su, Jingqian [1 ,2 ]
机构
[1] Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fuzhou 350117, Fujian, Peoples R China
[2] Fujian Normal Univ, Key Labs Innate Immune Biol Fujian Prov, Fuzhou 350117, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
sepsis; pathogenesis; biomarkers; therapeutic drugs; SYSTEMIC INFLAMMATORY RESPONSE; DISSEMINATED INTRAVASCULAR COAGULATION; INTERNATIONAL CONSENSUS DEFINITIONS; HUMAN SOLUBLE THROMBOMODULIN; PATTERN-RECOGNITION RECEPTORS; ENDOPLASMIC-RETICULUM STRESS; POLYMYXIN-B HEMOPERFUSION; ORGAN FAILURE ASSESSMENT; CRITICALLY-ILL PATIENTS; NATURAL-KILLER-CELLS;
D O I
10.3390/ijms20215376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sepsis is defined as "a life-threatening organ dysfunction caused by a host's dysfunctional response to infection". Although the treatment of sepsis has developed rapidly in the past few years, sepsis incidence and mortality in clinical treatment is still climbing. Moreover, because of the diverse manifestations of sepsis, clinicians continue to face severe challenges in the diagnosis, treatment, and management of patients with sepsis. Here, we review the recent development in our understanding regarding the cellular pathogenesis and the target of clinical diagnosis of sepsis, with the goal of enhancing the current understanding of sepsis. The present state of research on targeted therapeutic drugs is also elaborated upon to provide information for the treatment of sepsis.
引用
收藏
页数:31
相关论文
共 50 条
  • [31] Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets
    Hao Zhou
    Wenqiong Xiang
    Guangyu Zhou
    Fernando Rodrigues-Lima
    Fabien Guidez
    Li Wang
    Medical Oncology, 42 (1)
  • [32] The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets
    Lotfi, Ramin
    Kalmarzi, Rasoul Nasiri
    Rajabinejad, Misagh
    Hasani, Sabah
    Zamani, Fatemeh
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [33] New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets
    Liu, Wei Jing
    Reiser, Jochen
    Park, Tae Sun
    Liu, Zhangsuo
    Ishibe, Shuta
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [34] Clostridium perfringens Sialidases: Potential Contributors to Intestinal Pathogenesis and Therapeutic Targets
    Li, Jihong
    Uzal, Francisco A.
    McClane, Bruce A.
    TOXINS, 2016, 8 (11)
  • [35] Utilize proteomic analysis to identify potential therapeutic targets for combating sepsis and sepsis-related death
    Zhang, Tianlong
    Shi, Yin
    Li, Jiayue
    Huang, Peiyao
    Chen, Kun
    Yao, Jiali
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [36] Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets-An Updated View
    Schulte, Wibke
    Bernhagen, Juergen
    Bucala, Richard
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [37] The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets
    Hong, Qianya
    Zhu, Shuainan
    Yu, Ying
    Ren, Yun
    Jin, Lin
    Wang, Huilin
    Zhang, Hao
    Guo, Kefang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2024,
  • [38] Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets
    Ruenjaiman, Vichaya
    Hirankarn, Nattiya
    Palaga, Tanapat
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2021, 39 (02): : 69 - 77
  • [39] CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets
    Deshpande, Deepak A.
    Guedes, Alonso G. P.
    Lund, Frances E.
    Subramanian, Subbaya
    Walseth, Timothy F.
    Kannan, Mathur S.
    PHARMACOLOGY & THERAPEUTICS, 2017, 172 : 116 - 126
  • [40] Nonalcoholic fatty liver disease: Pathogenesis and potential for nuclear receptors as therapeutic targets
    George, Jacob
    Liddle, Christopher
    MOLECULAR PHARMACEUTICS, 2008, 5 (01) : 49 - 59